Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07868679
PHASE2

THiamine for Recovery In Vulnerable Early-life Infections

Sponsor: Milton S. Hershey Medical Center

View on ClinicalTrials.gov

Summary

To determine if the addition of thiamine to standard-of-care treatment will improve neurodevelopmental outcomes for infants with meningitis or bacteremia

Key Details

Gender

All

Age Range

Any - 12 Months

Study Type

INTERVENTIONAL

Enrollment

240

Start Date

2026-12-01

Completion Date

2031-11-30

Last Updated

2026-10-09

Healthy Volunteers

No

Interventions

DRUG

thiamine hydrochloride 100 mg

Patients will receive 100mg of IV thiamine in addition to standard-of-care treatment, once a day for three days

OTHER

Placebo

Participants will receive placebo in addition to standard-of-care treatment

Locations (2)

Boston Children's Hospital

Boston, Massachusetts, United States

Penn State Health Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States